OTC Packaging Should Fit Labeling, FDA's Ganley Says
This article was originally published in The Tan Sheet
Executive Summary
OTC manufacturers should tailor product packaging to fit the labeling required under FDA's final rule rather than "chop away at the labeling rule to make it fit onto the package," Division of OTC Drugs Director Charles Ganley, MD, told industry reps at a working group meeting in Rockville, Md. Nov. 23.
You may also be interested in...
OTC Labeling Trade Dress Issues Resolved In FDA Technical Amendment
Labeling of over-the-counter drug products may include light type on a dark background providing the combination results in a highly readable contrast, FDA asserts in a technical amendment to the OTC label final rule published in the Jan. 3 Federal Register.
OTC Labeling Trade Dress Issues Resolved In FDA Technical Amendment
Labeling of over-the-counter drug products may include light type on a dark background providing the combination results in a highly readable contrast, FDA asserts in a technical amendment to the OTC label final rule published in the Jan. 3 Federal Register.
OTC Labeling Trade Dress Issues Resolved In FDA Technical Amendment
Labeling of over-the-counter drug products may include light type on a dark background providing the combination results in a highly readable contrast, FDA asserts in a technical amendment to the OTC label final rule published in the Jan. 3 Federal Register.